Ontology highlight
ABSTRACT:
SUBMITTER: Huang S
PROVIDER: S-EPMC7476860 | biostudies-literature | 2020 Aug
REPOSITORIES: biostudies-literature
iScience 20200812 9
The emerging immune checkpoint blockade (ICB) therapy has ushered the cancer therapeutics field into an era of immunotherapy. Although ICB treatment provides remarkable clinical responses in a subset of patients with cancer, this regimen fails to extend survival in a large proportion of patients. Here, we found that a combined treatment of estrogen receptor beta (ERβ) agonist and PD-1 antibody treatment improved therapeutic efficacy in mouse tumor models, compared with monotherapies, by reducing ...[more]